Nuclear Medicine Research Sets New Standards for Treating Alzheimer’s

Alzheimer’s Disease affects nearly six million people in the U.S. today, a number expected to more than double by 2050. While current FDA-approved treatments can slow progression, they don’t reverse the disease—and come with serious side effects, including brain swelling. The question researchers are racing to answer is: Can we develop a safer, more effective […]

Read More